(DBXS) Xtrackers - Switzerland - Ratings and Ratios
Switzerland, Equity, ETF, Index, Tracker
Description: DBXS Xtrackers - Switzerland
The Xtrackers - Switzerland UCITS ETF is a Germany-originated exchange-traded fund that tracks the Morningstar Switzerland TME NR CHF Index, providing investors with exposure to the Swiss equity market. With a substantial Assets Under Management (AUM) of 1.34 billion EUR, this ETF is a significant player in the Switzerland Equity category.
Analyzing the ETFs recent price action, we observe that the last price is 136.36, slightly below the 20-day Simple Moving Average (SMA) of 136.74, indicating a neutral short-term trend. However, the 50-day SMA of 133.43 and 200-day SMA of 132.63 are both below the current price, suggesting a longer-term uptrend. The Average True Range (ATR) of 1.36, equivalent to 1.00%, indicates moderate volatility.
Considering the ETFs technical and fundamental data, we can forecast its potential future performance. Given the current price is near the 20-day SMA and the longer-term SMAs are supportive, we expect a continued consolidation phase in the short term. However, if the ETF can break above the 52-week high of 142.32, it may signal a strong bullish trend. Conversely, a drop below the 52-week low of 119.90 could indicate a significant downturn. With a substantial AUM and a track record of following the Morningstar Switzerland TME NR CHF Index, this ETF is likely to remain a popular choice for investors seeking Swiss equity exposure.
Based on the available data, a potential trading strategy could involve monitoring the ETFs price action around the 136-137 range, with a potential buy signal if it breaks above 142.32, targeting a new high, or a sell signal if it falls below 133.43, indicating a potential reversal of the longer-term uptrend.
Additional Sources for DBXS ETF
DBXS ETF Overview
Market Cap in USD | 1,553m |
Category | Switzerland Equity |
TER | 0.31% |
IPO / Inception | 2007-01-22 |
DBXS ETF Ratings
Growth Rating | 51.6 |
Fundamental | - |
Dividend Rating | 50.6 |
Rel. Strength | -20.6 |
Analysts | - |
Fair Price Momentum | 127.77 EUR |
Fair Price DCF | - |
DBXS Dividends
Dividend Yield 12m | 1.54% |
Yield on Cost 5y | 2.07% |
Annual Growth 5y | 4.32% |
Payout Consistency | 91.7% |
Payout Ratio | % |
DBXS Growth Ratios
Growth Correlation 3m | -0.4% |
Growth Correlation 12m | 42.6% |
Growth Correlation 5y | 85.3% |
CAGR 5y | 5.96% |
CAGR/Max DD 5y | 0.36 |
Sharpe Ratio 12m | 0.75 |
Alpha | -6.44 |
Beta | 0.441 |
Volatility | 10.91% |
Current Volume | 7.4k |
Average Volume 20d | 5.8k |
Stop Loss | 129.4 (-3%) |
As of July 16, 2025, the stock is trading at EUR 133.42 with a total of 7,382 shares traded.
Over the past week, the price has changed by -0.27%, over one month by -0.49%, over three months by +3.11% and over the past year by +2.17%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers - Switzerland (XETRA:DBXS) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.62 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBXS is around 127.77 EUR . This means that DBXS is currently overvalued and has a potential downside of -4.23%.
Xtrackers - Switzerland has no consensus analysts rating.
According to our own proprietary Forecast Model, DBXS Xtrackers - Switzerland will be worth about 141.7 in July 2026. The stock is currently trading at 133.42. This means that the stock has a potential upside of +6.18%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 141.7 | 6.2% |